EVHNYSEServices-Management ServicesFiscal year ends December 31
Evolent Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.48−0.09 (-1.97%)
Close on Oct 19, 2026
- Market cap
- $504.19M
- P/E (TTM)
- –
- Dividend yield
- –
Evolent Health, Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evolent Health Services Segment | $2.10B | $1.89B | $1.88B | $2.05B | $2.20B | $2.40B | $2.55B | $2.46B | $2.35B | $2.18B | $1.96B | $1.79B | 100.0% | -4.5% |
| Reportable segment | $2.10B | $1.89B | $1.88B | $2.05B | $2.20B | $2.40B | $2.55B | – | – | – | – | – | 100.0% | -4.5% |
By product or service
By region
From the segment and revenue-disaggregation notes of Evolent Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.